Ionis Pharmaceuticals IONS Available For Sale Securities Debt Maturities After One Through Two Years Percentage
Available For Sale Securities Debt Maturities After One Through Two Years Percentage at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsPercentage.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's available for sale securities debt maturities after one through two years percentage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's available for sale securities debt maturities after one through two years percentage?
- Ionis Pharmaceuticals (IONS) reported available for sale securities debt maturities after one through two years percentage of 27% in Q1 2026.
- How has Ionis Pharmaceuticals's available for sale securities debt maturities after one through two years percentage changed year-over-year?
- Ionis Pharmaceuticals's available for sale securities debt maturities after one through two years percentage decreased by 0.0% year-over-year, from 27% to 27%.
- What does available for sale securities debt maturities after one through two years percentage mean?
- The portion of debt investments maturing between one and two years.
- How do you interpret available for sale securities debt maturities after one through two years percentage?
- Shifts in this percentage indicate changes in the company's duration strategy for its cash reserves and investment portfolio.
- How does available for sale securities debt maturities after one through two years percentage compare across companies?
- Standard metric for assessing the maturity ladder of corporate investment portfolios.